Clinical Trials in Aberdeen, Aberdeen City

Find clinical trials in Aberdeen, Aberdeen City. Discover local research opportunities and treatment options in your area.

7 Active Trials Found in Aberdeen

Showing 7 trials on this page

Page 1 of 1

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

NCT ID: NCT06119581

This clinical trial is investigating whether a new drug called LY3537982, combined with standard cancer treatments like immunotherapy and chemotherapy, is more effective for patients with advanced ...

Recruiting

Phase: PHASE3 Conditions: Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

NCT ID: NCT06383390

The TRIUMPH-OUTCOMES study is looking at a new treatment called retatrutide, which is given once a week, to see if it can help reduce serious heart problems and protect kidney function in adults wh...

Recruiting

Phase: PHASE3 Conditions: Chronic Kidney Disease (CKD), Atherosclerotic Cardiovascular Disease (ASCVD)

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

NCT ID: NCT05139017

This clinical trial is studying a new treatment called zilovertamab vedotin (ZV) to see how well it works when combined with standard treatments for patients with a type of blood cancer known as re...

Recruiting

Phase: PHASE2 Conditions: Diffuse Large B-Cell Lymphoma, DLBCL

A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)

NCT ID: NCT05490446

This clinical trial is studying a medication called tebapivat for people with a condition known as lower-risk myelodysplastic syndromes (LR-MDS), which causes anemia (a low level of red blood cells...

Recruiting

Phase: PHASE2 Conditions: Myelodysplastic Syndromes

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

NCT ID: NCT03486873

This clinical trial, called MK-3475-587, is looking into the long-term safety and effectiveness of a treatment called pembrolizumab (also known as MK-3475) for patients with advanced tumors. If you...

Recruiting

Phase: PHASE3 Conditions: Solid Tumors, Hematologic Malignancies

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

NCT ID: NCT05254171

This clinical trial is looking at a combination treatment for patients with metastatic pancreatic cancer, specifically using two standard drugs called nab-paclitaxel and gemcitabine, with or withou...

Recruiting

Phase: PHASE2 Conditions: Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Metastatic +1 more

Real-time Soft Tissue Assessment Using a Technologically Advanced pH Monitoring System

NCT ID: NCT04725604

This clinical trial is studying a new way to diagnose Acute Compartment Syndrome (ACS), which can happen when blood flow to an injured limb is reduced, often after a fracture or crush injury. Early...

Not yet recruiting

Phase: NA Conditions: Acute Compartment Syndrome

Search All Trials Browse All Locations